Browse all articles >
Reply to “Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B”
Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection2023 October;29(4)
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection2023 July;29(3)
The role of different viral biomarkers on the management of chronic hepatitis B2023 April;29(2)
KASL clinical practice guidelines for management of chronic hepatitis B2022 April;28(2)